STOCK ALARM
PRO
SA
PRO
Explore
Screener
Alerts
Themes
Research
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Edwards Lifesciences Corporation
EW
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$6B
↑12%
Gross Profit
$5B
↑10%
Operating Income
$2B
↑19%
Net Income
$1B
↓74%
EBITDA
$1B
↓17%
EPS Diluted
1.8
Cost of Revenue
$1B
Gross Margin %
78.1%
R&D Expenses
$1B
SG&A Expenses
$2B
Operating Expenses
$3B
Operating Margin %
27.0%
Interest Expense
$0
Income Before Tax
$1B
Income Tax Expense
$217M
Net Margin %
17.7%
EPS
1.8
Shares Out (Diluted)
585.8M
Shares Out (Basic)
584.8M
Total Costs & Expenses
$4B
Interest Income
$148M
EBITDA Margin %
23.6%
Pre-Tax Margin %
21.0%
Other Income/Expenses
$-363M
Revenue CAGR (5Y)
+6.7%
Margin Trend
stable
Free Cash Flow
$1.3B
Profitability
Profitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
5,233
5,382
↑2.9%
5,010
↓6.9%
5,440
↑8.6%
6,068
↑11.5%
Gross Profit
4,007
4,215
↑5.2%
3,973
↓5.8%
4,322
↑8.8%
4,741
↑9.7%
Operating Income
1,610
1,702
↑5.7%
1,427
↓16.2%
1,379
↓3.4%
1,636
↑18.7%
Net Income
1,503
1,522
↑1.3%
1,402
↓7.9%
4,175
↑197.7%
1,074
↓74.3%
EBITDA
1,890
1,960
↑3.7%
1,535
↓21.7%
1,723
↑12.3%
1,430
↓17.0%
EPS Diluted
2.38
2.44
↑2.5%
2.30
↓5.7%
6.97
↑203.0%
1.83
↓73.7%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages